JP Morgan Call 260 CHTR 16.01.202.../ DE000JK63Q60 /
21/06/2024 11:13:00 | Diferencia- | Bid8:44:48 | Ask8:44:48 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.780EUR | - | 0.830 Volumen de oferta: 15,000 |
0.870 Tamaño/ Volumen/ Formato de Ask: 15,000 |
Charter Communicatio... | 260.00 USD | 16/01/2026 | Call |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página